Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT01005693
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed cancer
* Undergoing out-patient care
* Planning to undergo primary chemotherapeutic treatment or treatment with targeted agents for curative or palliative intent
* No symptomatic brain metastases
PATIENT CHARACTERISTICS:
* Able to understand the Flemish language, give informed consent, and be followed at the investigational site
* Must be considered eligible for trial participation by the Investigator
* No severe known dementia
* No pre-existing major neurological or psychiatric problems
* No refusal of the standard anticancer strategy as defined by the service instruction book
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT01005693
Study Brief:
Protocol Section:
NCT01005693